- Gilead Sciences Inc has priced its COVID-19 drug candidate remdesivir at $2,340 for a five-day treatment in the United States and some other developed countries, potentially reflecting looming competition from a cheap steroid.
Remdesivir is at the forefront of the fight against COVID-19 after the anti-viral treatment helped shorten hospital recovery times in a clinical trial. It has been approved for emergency use in some patients in the United States.The remdesivir price for U.S. private insurance companies will be $520 per vial, Gilead said, which equates to $3,120 per patient for a treatment course of six vials.Analysts at Royal Bank of Canada said they saw revenue potential of $2.
HHS has secured more than 500,000 treatment courses of the drug for U.S. hospitals through September, the agency said on Monday. Remdesivir's price has been a topic of intense debate since U.S. regulators approved its emergency use in some COVID-19 patients in May. Experts have said Gilead would need to avoid appearing to take advantage of a health crisis for profits.
WHAT A STEAL!!!
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Gilead sets price for Covid-19 treatment as HHS secures dosesThat puts the price of a five-day treatment course at $2,340 per patient for people enrolled in federal health programs. For the record: This replaces a deleted thread that misstated the price for remdesivir in the U.S. and the nature of the government's agreement with Gilead. 'five-day treatment course at $2,340 per patient' LOL DOWN from MSRP of $5,080 (€4,532) per 10-day course, COMPETITIVE with generic brand 5,000 - 6,000 INR (€59-€71) Save 4 days off your 12-60 day expected recovery. Its fire sale and a floor wax!
Source: politico - 🏆 381. / 59 Read more »
Gilead prices COVID-19 drug candidate remdesivir at $2,340 per patient in U.S.Gilead Sciences Inc has priced its COVID-19 drug candidate remdesivir at $390 per vial for the United States and governments of other developed countries, it said on Monday, setting the price of a five-day course at $2,340 per patient. See? It's all about MONEY gotta make a buck while people die
Source: Reuters - 🏆 2. / 97 Read more »
Women 'on precipice' in developing countries amid COVID-19The COVID-19 pandemic means that millions of women in Africa and other developing regions could lose years of success in contributing to household incomes, asserting their independence and expanding financial inclusion. Sing along please 🎶 Kurds are not terroist ❤️☀️💚don’t stay silent TurkeyInvadesKurdistan With 19 Dictators in African Nations it's not surprising. We think we have it bad in a Democracy imagine being in a government like that, China, Cuba,NKorea or Russia
Source: ABC - 🏆 471. / 51 Read more »
How U.S. Prisons Became Ground Zero for Covid-19Tight quarters, strained hygiene practices and guards moving to and from their community put prisons at risk of becoming coronavirus hotbeds. So! Whats the deathrate ? ThisIsAmerica US Bakery Refuses To Serve Muslim Woman In Niqab For Not Wearing 'Mask' StopIslamophobia stophating According to the MSM all they need to do is wear a mask.
Source: politico - 🏆 381. / 59 Read more »
How Boeing’s Confident Travel Initiative Works To Minimize Covid-19 SpreadHere's how Boeing’s confident travel initiative works to minimize the Covid-19 spread:
Source: Forbes - 🏆 394. / 53 Read more »
Why are similar countries experiencing COVID-19 so differently?The US has new coronavirus infection rates that look more like countries that spend much less on health care, particularly Brazil and Russia. - MeetThePress MeetThePress MeetThePress Well. The wall didn't really help here I see. MeetThePress If we didn't have so many dumbasses not wearing masks we might actually be doing better
Source: NBCNews - 🏆 10. / 86 Read more »